The headline trial results will be closely monitored by pharmaceutical industry experts. Shares in Novo Nordisk, which ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

Novo Nordisk is working on a new obesity drug that could help patients shed more than any other weight-loss drug on the ...

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

Not only is Wegovy extremely effective (people lose about 15% of their body weight in a year), it also appears to have many ...

There has been a lot of excitement since the launch. Not only is the drug extremely effective (people lose about 15 percent ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases ...

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

The weight-loss jab Wegovy made its debut on June 4 2021 . It was the first new weight-loss drug to be approved by the US ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

In a study published in Nature, scientists outlined a powerful new drug candidate that lowers appetite without loss of muscle ...